Blue Ocean Equities | Drugs Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

1,189 results for “Blue Ocean Equities”

BLUE-181

Pacific ocean perch

Investigational

Evans blue

C₃₄H₂₄N₆Na₄O₁₄S₄

Imipramine blue

Patent Blue

Conditions: Circulatory Disorders

C₂₇H₃₃N₂O₇S₂

Cibacron Blue

C₂₉H₂₀ClN₇O₁₁S₃

Prussian blue(Radiogardase)

Conditions: Internal contamination caused by radioactive or non-radioactive thallium, Internal contamination with radioactive cesium

C₁₈Fe₇N₁₈

Blue crab

CHI3L1xCTLA4(Ocean Biomedical)

Isosulfan blue(Lymphazurin)

Conditions: Chylothorax, Chylous Ascites +4 more

C₂₇H₃₃N₂O₆S₂

Page 1 of 11